Today, Johnson & Johnson shared its 2022 fourth-quarter and full-year earnings report.
Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with 144,000 employees across the globe working every day to help change the trajectory of health for humanity.
“Johnson & Johnson delivered solid results and demonstrated competitive growth across our business segments in 2022, while managing ongoing macroeconomic challenges,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “We are particularly proud of the pipeline and portfolio advancements in our Pharmaceutical and MedTech businesses as well as the continued progress toward the planned separation of our Consumer Health business, all of which will fortify the foundation for long-term value creation.”
For more details about the company’s 2022 fourth-quarter and full-year results, and to read a message from Chairman of the Board and Chief Executive Officer Joaquin Duato, here’s an infographic highlighting key stats.
Johnson & Johnson’s 2022 Earnings
You are now leaving jnj.com
The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.
